Biologics by McKesson Launches Oncology Pharmacy Solution to Improve Access to Care

A new pharmacy management solution, ScriptPAS, has been launched by McKesson. The fee-for-service solution is expected to help improve medication adherence in oncology patients and to reduce many of the barriers facing patients when seeking treatment.

“ScriptPAS services also help practices mitigate temporary staffing and overflow challenges, an important benefit as practices deal with the impacts of COVID-19 and the growth of oral oncolytics on their operations. Biologics works closely with providers to deliver best-in-class patient care and improve patient outcomes by helping patients access therapies faster and stay adherent. Biologics offers more than 150 therapies, including over 100 orals, at least 12 therapies exclusive to Biologics and more than another 60 therapies in limited-distribution networks distribution.” Read more here.

(Source: John Santilli, Access Market Intelligence, 3/23/21)